These findings indicate that FZD2 controls limb development by mediating both canonical and non-canonical Wnt pathways and reveal causality of pathogenic FZD2 mutations in RS and OMOD2 patients. This evidence concerns the gene FZD2 and autosomal dominant omodysplasia.